Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Published in The New England Journal of Medicine on June 13, 2019, this study evaluates the cardiovascular safety and efficacy of oral ...
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
Published in The New England Journal of Medicine on May 11, 2025, this phase 3b, open-label, randomized trial compares the efficacy and...
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Published in The New England Journal of Medicine on February 10, 2021, this study investigates the efficacy and safety of once-weekly s...
Two-Year Effects of Semaglutide in Adults with Overweight or Obesity: The STEP 5 Trial
Published in Nature Medicine on October 10, 2022, this phase 3, double-blind, randomized, placebo-controlled trial (STEP 5) evaluates t...
Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State—New Directions in Anti-Aging Regenerative Therapies
Published in Cells on June 15, 2021, this review article explores the potential of developmentally essential secreted peptides, particu...